To gain further insight into the molecular features of CD14+ monocytes in these severely affected patients with COVID-19 during acute and convalescent stages, we selected only hospitalized patients from our cohort and age- and sex-matched controls, and we performed global transcriptional profiling. The gene discussed is CD14; the disease is COVID-19.